Cart mincart
home
Search Results

Current Therapies for the Management of Diabetes Mellitus

by Instructor: Linda Yee PharmD, MPH, BCPS

$32.00

i 2.00 Hours

Course Overview

Diabetes is a prevalent condition that affects 422 million people worldwide. The cost of treating diabetes in the U.S. in 2012 was estimated to be $245 billion. Diabetes complicates many conditions and can lead to life-threatening complications such as diabetic ketoacidosis or hyperosmolar hyperglycemia states. There is no cure for diabetes; however, it is manageable. It is important to review the American Diabetes Association (ADA) standards of care guidelines; the most recent version was released in January 2017. Because there have been a number of new therapies and medications approved for the management of diabetes, it is more important than ever for pharmacists to understand the differences, benefits, and limitations of the various medications in order to optimize patient-specific care.

About the Course Author

Dr. Linda Yee is a board-certified clinical pharmacist practicing in a Level I trauma center in Brookdale Hospital Medical Center in the underserved Brownsville area of Brooklyn. She also has helped establish a CDTM-certified medication management clinic, which sees patients with chronic conditions such as asthma, COPD, heart failure, and diabetes. She received her doctor of pharmacy from Long Island University and her master’s degree in public health from Johns Hopkins University. 

Linda Yee PharmD, MPH, BCPS has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.

Get started now and your first course is free!

Become a member today and enjoy instant savings on all courses
GET CE-PRO

Accreditation Information

Certificates provided by accrediting body (2 Match)

  • Accreditation Council for Pharmacy Education

    2.00HOURS

    In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


    Type Activity: Knowledge
    Target Audience Designation: P
    ACPE Universal Activity Number: JA4008266-0000-21-154-H01-P

  • Florida Board of Pharmacy

    2.00HOURS

    This module is approved for 2.0 contact hours by Florida Board of Pharmacy


Course Details

  • Course Code:

    REL-ACU-0-PHARM154

  • Hours:

    2.00

  • Type:

    Online Course

  • Release Date:

    2020-04-01

  • Expiration Date:

    2021-11-30

  • Learning Objectives:

    Identify hypoglycemia risk, severity levels, and treatment options; Identify the different diabetes classifications; List the goals associated with glycemic targets and blood pressure from updated guidelines for diabetes management; Review current nonpharmacological and pharmacological treatment options for diabetes; Review the diagnostic criteria for diabetes; Review the prevalence and economic burden of patients with diabetes

  • Target Audience:

    The target audience for this course is: Nurses; Pharmacists; in the following settings: Acute Care Facility.

  • Course Delivery Method and Format:

    Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
    Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
    If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
    All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
    Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
    All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
    To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.

  • Accommodations:

    If you require special accommodations to complete this module, please contact Relias Customer Support here.

  • Disclosures:

    Expert Reviewers, Instructors, and Staff Writers disclosures will be listed above after the individuals' biographical paragraph. All other members involved within the planning of this educational activity have declared no conflict of interest exists when planning and developing this course.